CATALENT PHARMA SOLUTIONS

Catalent Inhalation has the capabilities, expertise and state-of-the-art facilities to expedite product development, from concept and feasibility studies through commercial manufacture and release testing. With over 30 years of inhalation product experience, Catalent can handle the most complex projects and help bring your therapy to market, faster. Whether a single service or a comprehensive development package is required, Catalent offers end-to-end expertise across dose forms:

• Dry Powder Inhalers (DPIs)
• Metered-Dose Inhalers (MDIs)
• Unit and Bi-Dose Nasal Sprays

Catalent also provides comprehensive analytical, particle size engineering and clinical trial supply services. Visit Website